Mr. Podlesak joined Domain as a Partner in 2007. Prior to Domain, Mr. Podlesak was a founder and the Chief Executive Officer of Cerexa Pharmaceuticals, which became a wholly-owned subsidiary of Forest Laboratories after Mr. Podlesak led the growth and sale of the company to Forest in January 2007. Prior to Cerexa, Mr. Podlesak was the Chief Executive Officer of Peninsula Pharmaceuticals, and after building the company, led the sale of Peninsula to Johnson & Johnson in June 2005.

Mr. Podlesak has over 20 years of strategic, operational and commercial experience within the pharmaceutical industry, and a track record of success growing companies and leading business development & licensing, financing and M&A initiatives. Prior to Peninsula, Mr. Podlesak served as Senior Vice President and Head of a North American Business Unit for Novartis AG and as a member of Novartis' Pharmaceutical Executive Committee and Global Leadership Team. Earlier in his career, Mr. Podlesak served as Vice President and Head of the CEC division of Allergan, Inc. and as member of Allergan's North American and Global Management Team. Mr. Podlesak spent the first ten years of his career with SmithKline Beecham (now GlaxoSmithKline plc) where he was promoted to eight positions of increasing responsibility during his tenure with the company.

Mr. Podlesak currently serves as Chairman of the Board of Corthera, Inc. and Regado Biosciences, and is a Board member of Avanir Pharmaceuticals, Dov Pharmaceuticals, and the non-profit organization Prevent Blindness.